Gene · 435
Papers1,794
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,794
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Metabolic Features of Osteoblasts: Implications for Multiple Myeloma (MM) Bone Disease. | Int J Mol Sci | 2023 | 36902326 | PubTator, text mining | PubMed |
| Metabolomics in paraganglioma: applications and perspectives from genetics to therapy. | Endocr Relat Cancer | 2023 | 36897220 | PubTator, text mining | PubMed |
| Macrophage fumarate hydratase restrains mtRNA-mediated interferon production. | Nature | 2023 | 36890227 | PubTator, text mining | PubMed |
| Controlling the confounding effect of metabolic gene expression to identify actual metabolite targets in microsatellite instability cancers. | Hum Genomics | 2023 | 36879264 | PubTator, text mining | PubMed |
| Early allograft dysfunction in a pediatric liver allograft with an occult pathogenic mutation in the urea cycle. | Am J Transplant | 2023 | 36870389 | PubTator, text mining | PubMed |
| Assessment of microbiota in the gut and upper respiratory tract associated with SARS-CoV-2 infection. | Microbiome | 2023 | 36869345 | PubTator, text mining | PubMed |
| Fine particulate matter (PM2.5)-induced pulmonary oxidative stress contributes to changes in the plasma lipidome and liver transcriptome in mice. | Toxicol Sci | 2023 | 36857595 | PubTator, text mining | PubMed |
| Metabolomics Differences of the Donor Livers Between In Situ and Ex Situ Conditions During Ischemia-free Liver Transplantation. | Transplantation | 2023 | 36857152 | PubTator, text mining | PubMed |
| Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346/GSK-3β signaling pathway. | Cell Death Dis | 2023 | 36854759 | PubTator, text mining | PubMed |
| Hepatocellular Metabolic Abnormalities Induced by Long-Term Exposure to Novel Brominated Flame Retardant, Hexabromobenzene. | Toxics | 2023 | 36850976 | PubTator, text mining | PubMed |
| Competing particle attractee in liquid bridges. | Philos Trans A Math Phys Eng Sci | 2023 | 36842985 | PubTator, text mining | PubMed |
| Molecular mechanisms of atrazine toxicity on H19-7 hippocampal neurons revealed by integrated miRNA and mRNA "omics". | Ecotoxicol Environ Saf | 2023 | 36841081 | PubTator, text mining | PubMed |
| Untargeted Metabolomics Analysis Using UHPLC-Q-TOF/MS Reveals Metabolic Changes Associated with Hypertension in Children. | Nutrients | 2023 | 36839194 | PubTator, text mining | PubMed |
| Determination of Heterogeneous Proteomic and Metabolomic Response in anti-TNF and anti-IL-6 Treatment of Patients with Rheumatoid Arthritis. | Life (Basel) | 2023 | 36836953 | PubTator, text mining | PubMed |
| Epigenetics and Metabolism Reprogramming Interplay into Glioblastoma: Novel Insights on Immunosuppressive Mechanisms. | Antioxidants (Basel) | 2023 | 36829778 | PubTator, text mining | PubMed |
| The yeast ALA synthase C-terminus positively controls enzyme structure and function. | Protein Sci | 2023 | 36807942 | PubTator, text mining | PubMed |
| Coronary Vasospasm in a Patient With Argininosuccinic Aciduria. | Am J Cardiol | 2023 | 36807131 | PubTator, text mining | PubMed |
| Genome-wide association study identifies WWC2 as a possible locus associated with persistent pulmonary hypertension of the newborn in the Thai population. | Transl Pediatr | 2023 | 36798934 | PubTator, text mining | PubMed |
| Supplementation with Nitric Oxide Precursors for Strength Performance: A Review of the Current Literature. | Nutrients | 2023 | 36771366 | PubTator, text mining | PubMed |
| Fibrosis-Related Gene Profiling in Liver Biopsies of PiZZ α1-Antitrypsin Children with Different Clinical Courses. | Int J Mol Sci | 2023 | 36768808 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/435/papers?page=11